Product Program year 2024 Source: CMS Open Payments

Acclarent SE Inflation Device

Device Rhinology Otology

PDI 10705031230866

Open in the dashboard

General payments

$10,174

152 payments

Research payments

$0

0 payments

Through program year 2024, $10,174 in general payments and $0 in research payments were reported against Acclarent SE Inflation Device (Rhinology Otology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $2,787 4
2023 General $5,587 38
2022 General $655 50
2021 General $1,144 60

Breakdown

Who paid General payments · program years 2021–2024
  1. Acclarent, Inc $6,594 136 payments
  2. Medical Device Business Services, Inc. $3,461 2 payments
  3. Janssen Biotech, Inc. $66 4 payments
  4. Janssen Pharmaceuticals, Inc $53 10 payments
Top recipients General payments · program year 2024
  1. Dennis Poe Otolaryngology · Boston, MA $2,700 97% · 1 payment
  2. Ariel Waitzman Otolaryngology · Dearborn, MI $34 1% · 1 payment
  3. Frederick Lopatin Otolaryngology · Dearborn, MI $34 1% · 1 payment
  4. Matthew Farrugia Otolaryngology · Novi, MI $20 <1% · 1 payment

Each share is of general payments naming this product in 2024.

Specialties paid General payments · program year 2024
  1. Otolaryngology $2,787 100% · 4 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Massachusetts $2,700 97% · 1 recipient
  2. Michigan $87 3% · 3 recipients

Each share is of general payments naming this product in 2024 where a state was reported.

152 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record